| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 3 securities · passive | ||||||
|
Korsana Biosciences, Inc.
13G/A
KRSA · 23255M303
|
0.1% |
10/15/2026
Event 9/30/2026
|
||||
| J. Wood Capital Advisors LLC | 0.1% | |||||
| Jason Wood | 0.1% | |||||
|
Karyopharm Therapeutics Inc.
13G/A
KPTI · 48576U205
|
4.99% |
11/3/2025
Event 10/14/2025
|
||||
| J. Wood Capital Advisors LLC | 4.99% | |||||
| Jason Wood | 4.99% | |||||
|
Cyclerion Therapeutics, Inc.
13G
CYCN · 23255M204
|
5.4% |
10/17/2025
Event 3/25/2025
|
||||
| J. Wood Capital Advisors LLC | 5.4% | |||||
| Jason Wood | 5.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.